| Actoplus Met Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Actoplus Met 500 mg-15 mg | tablet | oral | 1.0 each | OTC |
| Actoplus Met 500 mg-15 mg | tablet | oral | 1.0 each | OTC |
| Actoplus Met 850 mg-15 mg | tablet | oral | 1.0 each | OTC |
GlaxoSmithKline.(Supplier News)(Brief article) - Therapeutics Daily (subscription) (press release)
... warnings about a risk of heart failure for Avandia, Actos and drugs used in combination with these medications, such as Avandamet and Actoplus Met. ...
Sat Dec 22 09:22:20 -0500 2007
medimpact Study Demonstrates Health Risks for Diabetics May be ... - PharmaLive.com (press release)
... compared compliance rates for diabetics taking TZD and MET agents as two separate pills with compliance rates for diabetics taking Actoplus Met(TM), ...
Tue Nov 06 13:29:24 -0500 2007
News source: Business Wire - Genetic Engineering News (press release)
The remaining Avandia patients switched to another agent were moved to pioglitazone, marketed as Actos, Actoplus Met and Duetact. ...
Thu Nov 29 14:04:30 -0500 2007
metformin hydrochloride - The hydrochloride salt form of metformin, a biguanide with antihyperglycemic activity. Metformin hydrochloride exerts its action by improving hepatic sensitivity to insulin, thereby suppressing hepatic glucose production and increasing hepatic glycogen stores. In addition, metformin hydrochloride increases the number and/or affinity of insulin receptors on cell surface membranes in muscle and adipose tissue, thereby increasing the sensitivity to insulin at receptor and post-receptor binding sites and increasing glucose uptake peripherally.
pioglitazone hydrochloride